[account_shop_links]
Accenture and Medpace Excel in Phase II/III Delivery Factors
The 10th Edition of ISR's Phase II/III CRO Benchmarking has arrived Informing pharmaceutical drug developers, manufacturers, and service providers. Raleigh, N.C. – May 17, 2018 – Industry Standard Research (ISR) has released a new report, the 10th edition of its…
